Comment
doi: 10.1200/JCO.1998.16.8.2892.
Letrozole for advanced breast cancer
- PMID: 9704745
- DOI: 10.1200/JCO.1998.16.8.2892
Item in Clipboard
Comment
Letrozole for advanced breast cancer
J Clin Oncol.
1998 Aug.
No abstract available
Comment on
-
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.J Clin Oncol. 1998 Feb;16(2):453-61. doi: 10.1200/JCO.1998.16.2.453. J Clin Oncol. 1998. PMID: 9469328 Clinical Trial.
Similar articles
-
Letrozole in breast cancer.N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30. N Engl J Med. 2004. PMID: 14971057 No abstract available.
-
Letrozole in breast cancer.N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30. N Engl J Med. 2004. PMID: 14971059 No abstract available.
-
Letrozole: updated duration of response.J Clin Oncol. 1999 Dec;17(12):3856-60. doi: 10.1200/JCO.1999.17.12.3856. J Clin Oncol. 1999. PMID: 10577865 No abstract available.
-
Drug update: letrozole: A new aromatase inhibitor for metastatic breast cancer.Cancer Pract. 1998 Nov-Dec;6(6):349-52. doi: 10.1046/j.1523-5394.1998.006006349.x. Cancer Pract. 1998. PMID: 9824427 Review. No abstract available.
-
An overview of letrozole in postmenopausal women with hormone-responsive breast cancer.Adv Ther. 2011 Dec;28(12):1045-58. doi: 10.1007/s12325-011-0075-4. Epub 2011 Nov 7. Adv Ther. 2011. PMID: 22068628 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
